...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Tripartite motif-containing protein 28 is a small ubiquitin-related modifier e3 ligase and negative regulator of IFN regulatory factor 7.
【24h】

Tripartite motif-containing protein 28 is a small ubiquitin-related modifier e3 ligase and negative regulator of IFN regulatory factor 7.

机译:包含三方基序的蛋白质28是小的泛素相关修饰物e3连接酶,是IFN调节因子7的负调节剂。

获取原文
获取原文并翻译 | 示例
           

摘要

IFN regulatory factor 7 (IRF7) is a potent transcription factor of type I IFNs and IFN-stimulated genes and is known as the master regulator of type I IFN-dependent immune responses. Because excessive responses could harm the host, IRF7 itself is delicately regulated at the transcriptional, translational, and posttranslational levels. Modification of IRF7 by small ubiquitin-related modifiers (SUMOs) has been shown to regulate IFN expression and antiviral responses negatively, but the specific E3 ligase needed for IRF7 SUMOylation has remained unknown. As reported in this article, we have identified the tripartite motif-containing protein 28 (TRIM28) as a binding partner of IRF7. We have demonstrated that TRIM28 also interacts with the SUMO E2 enzyme and increases SUMOylation of IRF7 both in vivo and in vitro, suggesting it acts as a SUMO E3 ligase of IRF7. Unlike the common SUMO E3 ligase, protein inhibitor of activated STAT1, the E3 activity of TRIM28 is specific to IRF7, because it has little effect on IRF7's close relative IRF3. TRIM28 is therefore, so far as we know, the first IRF7-specific SUMO E3 reported. TRIM28-mediated SUMOylation of IRF7 is increased during viral infection, and SUMOylation of transcription factors usually results in transcriptional repression. Overexpression of TRIM28 therefore inhibits IRF7 transactivation activity, whereas knockdown of TRIM28 has the opposite effect and potentiates IFN production and antiviral responses. Collectively, our results suggest that TRIM28 is a specific SUMO E3 ligase and negative regulator of IRF7.
机译:IFN调节因子7(IRF7)是I型IFN和IFN刺激的基因的有效转录因子,被称为I型IFN依赖性免疫应答的主要调节剂。由于过度反应可能会损害宿主,因此IRF7本身在转录,翻译和翻译后水平上均受到精细调节。小泛素相关修饰剂(SUMOs)对IRF7的修饰已显示负调节IFN表达和抗病毒反应,但IRF7 SUMOylation所需的特定E3连接酶仍然未知。如本文所述,我们已将包含三重基序的蛋白28(TRIM28)确定为IRF7的结合伴侣。我们已经证明,TRIM28还可与SUMO E2酶相互作用,并在体内和体外增加IRF7的SUMO酰化,表明它可作为IRF7的SUMO E3连接酶。与常用的SUMO E3连接酶(活化的STAT1的蛋白抑制剂)不同,TRIM28的E3活性对IRF7具有特异性,因为它对IRF7的近亲IRF3几乎没有影响。因此,据我们所知,TRIM28是第一个IRF7特定的SUMO E3。在病毒感染期间,TRIM28介导的IRF7的SUMOylation增加,并且转录因子的SUMOylation通常会导致转录抑制。因此,TRIM28的过表达抑制IRF7的反式激活活性,而敲低TRIM28具有相反的作用并增强IFN的产生和抗病毒反应。总的来说,我们的结果表明TRIM28是一种特定的SUMO E3连接酶,是IRF7的负调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号